What is Atripla?
Manufactured by Gilead Sciences, Atripla (generic: efavirenz/tenofovir disoproxil fumarate/emtricitabine) is designed to treat human immunodeficiency virus (HIV), the infection that causes acquired immunodeficiency syndrome (AIDS). It doesn’t cure HIV or AIDS, but instead may slow progress of the disease and prolong life. Atripla was approved by the U.S. Food & Drug Administration (FDA) on July 12, 2006.
What’s the Problem?
It has been alleged that the tenofovir disoproxil fumarate (TDF) in Atripla may contribute to kidney problems and bone demineralization due to compromised bone density. Gilead has been accused of placing consumers at an unnecessary risk of injury, seeing as the company could have released an equally effective product that was not so dangerous.
Atripla Side Effects
- Bone demineralization
- Loss of bone density
- Bone fractures
- Osteopenia
- Osteoporosis
- Kidney damage
- Kidney toxicity
- Chronic kidney disease (CKD)
- Kidney failure (renal failure)
- And more
Which Other HIV Drugs Contain Tenofovir?
In addition to Atripla, other HIV Medications that contain tenofovir include:
Atripla Recall
Despite being linked to bone loss, kidney damage and other serious side effects, Atripla has not been recalled by the FDA, and continues to be prescribed to unsuspecting HIV patients across the U.S. However, in Oct. 2018, the U.S. Department of Health and Human Services (DHHS) downgraded Atripla from a “recommended” regimen to an “alternative” regimen for people just beginning antiretroviral therapy (ART).
Why Our Firm is Filing Individual Lawsuits as Opposed to a Class Action
Although we are a nationally recognized class action firm, the Products Liability Litigation Group at our law firm has decided against the filing of an Atripla class action suit and is currently filing individual claims for individuals and/or their family members who suffered kidney or bone problems after using the drug.
We decided on this course of action because class action suits can be a detriment to many class members in this type of litigation, as they are often forced into a blanket “low ball settlement” and higher attorney fees. At Schmidt & Clark, LLP we understand that our clients are suffering emotionally and economically due to loss of wages and/or high medical bills and we plan to maximize each client’s recovery by filing individual Atripla lawsuits on their behalf.
Do I Have an Atripla Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Atripla lawsuits. We are handling individual litigation nationwide and currently accepting new bone density and kidney injury cases in all 50 states.
Free Case Evaluation: Again, if you or a loved one has been harmed by the side effects of Atripla, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.